Comprehensive rTMS treatment for depression.
EXOMIND™ rTMS is a non-invasive brain-stimulation treatment that may be considered for adults with major depressive disorder when symptoms remain significant despite prior care or when another evidence-informed treatment pathway is being explored.
Book a ConsultationWhat is rTMS for depression?
Repetitive transcranial magnetic stimulation uses targeted magnetic pulses to influence cortical regions and connected networks involved in mood regulation, motivation, attention and cognitive control.
Unlike psychotherapy, rTMS does not rely on talking through thoughts and emotions during the treatment itself. Unlike medication, it does not circulate through the whole body. Instead, stimulation is delivered externally through the scalp to a selected treatment target. Patients remain awake, no routine anesthesia is required, and most people return to their normal activities after a session.
Who may consider rTMS?
Persistent depressive symptoms
Low mood, reduced motivation, loss of interest, fatigue, impaired concentration, sleep disturbance or functional impairment continue despite previous care.
Incomplete response to treatment
Medication, psychotherapy or combined treatment has produced only partial improvement or symptoms return repeatedly.
Need for another treatment pathway
A patient and clinician want to consider a non-invasive treatment that can be integrated with other mental-health care.
What does a treatment course involve?
A treatment course typically begins with a consultation and safety review. The clinical target, treatment protocol, expected frequency of sessions and symptom measures are then established. Repeated sessions are usually required because the therapeutic goal is to influence neural activity and plasticity over time rather than create a one-time effect.
1. Clinical consultation
Review of diagnosis, symptom severity, previous treatments, medications, medical history, seizure risk and other relevant safety factors.
2. Treatment planning
Selection of protocol, treatment goals and outcome measures. The plan should explain why rTMS is being recommended and what improvement would look like.
3. Progress monitoring
Symptoms and functioning should be reviewed throughout treatment so the clinician can determine whether the patient is improving, plateauing or needs another approach.
How is improvement measured?
Response should be measured using more than a simple question about whether someone “feels better.” Clinically useful outcomes can include changes in depressive symptom severity, sleep, motivation, activity level, concentration, social functioning, work functioning and standardized symptom scores.
For some patients, improved functioning may appear before complete symptom remission. For others, symptom change may be limited and another treatment strategy may be required.
Safety, side effects and who may not be suitable
rTMS is generally considered non-invasive, but it still requires appropriate screening. Common treatment-related effects can include temporary scalp discomfort, headache or fatigue. Safety review is particularly important for people with a seizure history, certain implanted metallic or electronic devices, unstable medical conditions or medications that may alter seizure threshold.
Suitability should always be determined by a qualified clinician familiar with the patient’s full medical and psychiatric history.
How rTMS can fit with other treatments
rTMS does not necessarily replace psychotherapy, medication management or behavioural treatment. Depending on the clinical picture, it may be used alongside psychotherapy, medication prescribed by another provider, sleep interventions, exercise, behavioural activation or other supports.
When depression co-occurs with diagnostic uncertainty, attention problems, trauma symptoms or complex cognitive concerns, psychological assessment may help clarify treatment planning. qEEG brain mapping and neurofeedback may be considered separately where clinically appropriate.
Frequently asked questions
Is rTMS an established treatment for depression?
Yes. TMS has an established evidence base for major depressive disorder, although specific devices, targets, protocols and schedules vary.
How soon do people notice changes?
Response timing varies. Some people notice gradual change during the treatment course, while others require more time or may have limited response.
Can rTMS be combined with psychotherapy?
Yes, when clinically appropriate. The approaches work through different mechanisms and can be integrated within one treatment plan.
Do I have to stop medication?
Not necessarily. Medication decisions should be made with the prescribing clinician. rTMS may be used alongside medication depending on the clinical situation.
Does treatment require anesthesia?
No routine anesthesia is required. Patients remain awake during treatment.
How many sessions are needed?
The number and frequency of sessions depend on the protocol, diagnosis, severity and individual response.
What if I do not respond?
Lack of response should prompt a review of diagnosis, treatment target, protocol, adherence, comorbid conditions and alternative treatment options.
Considering rTMS for depression in Calgary?
Book a consultation to discuss whether EXOMIND may fit within your individualized treatment plan.
Book a ConsultationExplore the main EXOMIND rTMS Calgary service page for treatment overview, candidacy and booking information.
Explore the Brain Optimization Calgary pathway
Understand how assessment, psychological strategies, neurofeedback, qEEG and EXOMIND may fit within one individualized clinical pathway.
Brain Optimization CalgaryrTMS Calgary: Cost, Access and Effectiveness
How much does rTMS cost in Calgary?
rTMS costs vary according to the clinical indication, individualized treatment plan and number of sessions recommended. Calgary Mind & Wellness Clinic reviews expected fees, scheduling and possible insurance questions during consultation before treatment begins.
Is rTMS available in Alberta?
Yes. Calgary Mind & Wellness Clinic provides clinician-guided EXOMIND rTMS services in Calgary, Alberta. An individualized screening consultation is required to determine whether the service is appropriate and whether another assessment or treatment pathway should be considered.
Does rTMS really work for depression?
Research supports rTMS as a treatment option for some people with depression, particularly when symptoms have not improved adequately with standard approaches. Outcomes vary, and no specific result can be guaranteed. Suitability, risks, alternatives and progress should be reviewed with a qualified clinician.
Learn more about EXOMIND rTMS in Calgary or contact the clinic to discuss individualized screening.